Dynavax Technologies Corp banner

Dynavax Technologies Corp
F:DYF1

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
F:DYF1
Watchlist
Price: 12.805 EUR
Market Cap: €1.7B

Wall St Price Targets

DYF1 Price Targets Summary
Dynavax Technologies Corp

There are no price targets for DYF1.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Dynavax Technologies Corp Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
29% Upside
AYTU
Aytu Biopharma Inc
344% Upside
CIGI
Colliers International Group Inc
9% Upside
OFIX
Orthofix Medical Inc
32% Upside
QTTB
Homology Medicines Inc
-6% Downside

Revenue
Forecast

22% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
22% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 8 years is 16%.

Gross Profit
Forecast

N/A
Past Growth
-54% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-54% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 7 years is -54%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DYF1's stock price target?
Not Available

DYF1 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Dynavax Technologies Corp?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 8 years is 16%.

What is the Gross Profit forecast for Dynavax Technologies Corp?
Projected CAGR
-54%

The compound annual growth rate for Gross Profit over the next 7 years is -54%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett